A detailed history of Tiger Global (Tiger Global Management LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Tiger Global Management LLC holds 1,269,000 shares of NVO stock, worth $138 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
1,269,000
Previous 1,269,000 -0.0%
Holding current value
$138 Million
Previous $181 Million 16.58%
% of portfolio
0.69%
Previous 0.86%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $57.7 Million - $127 Million
634,500 Added 100.0%
1,269,000 $115 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $99 Million - $110 Million
634,500 New
634,500 $103 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $245B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track Tiger Global's Portfolio

Track Tiger Global Portfolio

Follow Tiger Global (Tiger Global Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Global Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiger Global Management LLC and Tiger Global with notifications on news.